Agglutination Reactions of Artemisinin-Type Drugs and Other Substances

Author:

Yan Bin,Han Lihong,Gao Lijun,Qin Wenbin

Abstract

Artemisinin is a good antimalarial drug independently developed in China. It is highly effective and low toxic. In the process of studying the antimalarial mechanism of artemisinin drugs, we found that there was agglutination when the drugs came into contact with blood. Methods: ABO positive typing test card was used to detect the agglutination reaction of artemisinin and dihydroartemisinic with whole blood, red blood cells, hemolytic solution, hemin chloride, ferrous sulfate, ferric chloride, sodium chloride, DMSO and artemether. Results: artemisinin can agglutinate with many substances, such as red blood cells, red blood cell hemolytic solution, hemin chloride, ferrous sulfate, ferric chloride, sodium chloride and so on. The agglutination reaction in this paper is not related to antigen and antibody, but the result of the interaction between artemisinin drugs and various substances. Whole blood, red blood cells and hemolytic fluid contain biological macromolecular components. Hemin belongs to low molecular organic compounds, and the rest are simple inorganic compounds. Artemisinin drugs can interact with such a wide range of substances and agglutinate, indicating their strong effect. The mechanism is not clear. It is speculated that it is related to the “oxygen bridge” in artemisinin molecule, but the details of the action and how to agglutinate need to be studied. Interestingly, when artemether interacts with artemisinin and dihydroartemisinin, there is no agglutination, but there is a tendency of agglutination in the control, which is contrary to other results. This is a phenomenon, indicating that there is interaction, and its mechanism and significance need to be further studied. Artemisinin can interact with many substances.

Publisher

EDP Sciences

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3